AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,014 | 65,167 | 87,435 | 36,135 | 44,504 |
| Marketable Securities | 136,620 | 54,654 | 27,351 | 54,326 | 58,957 |
| Receivables | 1,275 | 992 | 17,179 | 460 | 337 |
| Other current assets | 445 | 305 | 274 | 353 | 751 |
| TOTAL | $199,626 | $125,596 | $139,408 | $97,537 | $110,297 |
| Non-Current Assets | |||||
| PPE Net | 3,235 | 3,699 | 3,761 | 4,105 | 4,183 |
| Investments And Advances | 459 | 474 | 402 | 409 | 402 |
| Intangibles | 55,745 | 57,631 | 56,158 | 57,061 | 56,083 |
| Other Non-Current Assets | 3,577 | 3,819 | 3,908 | 2,720 | 2,824 |
| TOTAL | $63,016 | $65,623 | $64,229 | $64,294 | $63,491 |
| Total Assets | $262,643 | $191,219 | $203,637 | $161,832 | $173,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,587 | 3,243 | 1,870 | 1,674 | 1,504 |
| Accrued Expenses | 13,152 | 12,049 | 12,350 | 10,569 | 9,809 |
| TOTAL | $111,156 | $16,145 | $15,122 | $13,253 | $12,407 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 95,657 | 85 | 154 | 383 | 478 |
| Other Non-Current Liabilities | 9,299 | 9,689 | 9,574 | 6,352 | 6,393 |
| TOTAL | $15,015 | $9,689 | $9,574 | $6,352 | $6,393 |
| Total Liabilities | $126,171 | $25,834 | $24,696 | $19,605 | $18,800 |
| Shareholders' Equity | |||||
| Common Shares | 2,446 | 2,393 | 2,327 | 2,040 | 2,002 |
| Retained earnings | -392,090 | -380,147 | -352,212 | -351,410 | -329,332 |
| Other shareholders' equity | -280 | -160 | -174 | -114 | -129 |
| TOTAL | $136,471 | $165,385 | $178,940 | $142,227 | $154,989 |
| Total Liabilities And Equity | $262,642 | $191,219 | $203,637 | $161,832 | $173,788 |